Reuters logo
BRIEF-Bill & Melinda Gates Foundation, Intarcia Therapeutics to develop anti-HIV prophylactic therapy
December 29, 2016 / 3:33 PM / a year ago

BRIEF-Bill & Melinda Gates Foundation, Intarcia Therapeutics to develop anti-HIV prophylactic therapy

Dec 29 (Reuters) - Intarcia Therapeutics:

* Bill & Melinda Gates Foundation will invest up to $140 million; $50 million as investment into Series EE round

* Bill & Melinda Gates Foundation investment also includes up to $90 million in non-dilutive milestone-based grants

* As part of financing, company enters into relationship with Bill & Melinda Gates Foundation to develop and advance an anti-HIV prophylactic Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below